99mTc scintigraphy predicts a successful of thyroid remnant radioiodine ablation in patients with differentiated thyroid carcinoma

被引：0
|
作者：
Zehnati, T. [1 ]
Benrabah, M. [1 ]
Bouzidi, A. [2 ]
Lakehal, A. [2 ]
Ouyed, T. [3 ]
Hamlat, R. [1 ]
Redhouane, L. [1 ]
机构：
[1] Univ Hosp Oran, Oran, Algeria
[2] Univ Hosp Constantine, Constantine, Algeria
[3] Canc Ctr Tizi Ouzou, Tizi Ouzou, Algeria
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0318
引用
收藏
页码：S557 / S558
页数：2
相关论文
共 50 条
  • [21] Different Radioiodine Dose for Remnant Thyroid Ablation in Patients With Differentiated Thyroid Cancer A Meta-analysis
    Song, Xinghua
    Meng, Zhaowei
    Jia, Qiang
    Zhang, Linlin
    Xu, Ke
    Tan, Jian
    Zhang, Guizhi
    Zheng, Wei
    Li, Xue
    Zhang, Jianping
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (10) : 774 - 779
  • [22] Thyroid remnant ablation of differentiated thyroid carcinoma: a comparison of ablation success with high and low doses of radioiodine (I-131)
    Elrasad, S. A. A.
    Abdelhafeez, Y.
    Husseini, M. A.
    Amin, R. A. A.
    Elrefaei, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S328 - S328
  • [23] Sensitivity of [99mTc]methoxyisobutylisonitrile scan in patients with metastatic differentiated thyroid cancer
    Ronga, G.
    Ventroni, G.
    Montesano, T.
    Filesi, M.
    Ciancamerla, M.
    Di Nicola, A. D.
    Travascio, L.
    Viestri, A. R.
    Signore, A.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 51 (04): : 364 - 371
  • [24] The Use of Radioiodine Uptake and Tc-99m pertechnetate Thyroid Scintigraphy in Predicting the Result of Postoperative Thyroid Remnant Ablation
    Thientunyakit, T.
    Pusuwan, P.
    Tuchinda, P.
    Kiewwan, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S349 - S349
  • [25] Postoperative radioiodine ablation in patients with low risk differentiated thyroid carcinoma
    Diez, Juan J.
    Grande, Enrique
    Iglesias, Pedro
    MEDICINA CLINICA, 2015, 144 (01): : 35 - 41
  • [26] Fractionated dosage of radioiodine for the ablation of differentiated thyroid carcinoma
    Czepczynski, R
    Ziemnicka, K
    Baczyk, M
    Oleksa, R
    Ruchala, M
    Sowinski, J
    THYROID, 2005, 15 (11) : 1261 - 1265
  • [27] Effectiveness of Reduced Radioiodine Activity for Thyroid Remnant Ablation after Total Thyroidectomy in Patients with Low to Intermediate Risk Differentiated Thyroid Carcinoma
    Todica, Andrei
    Haidvogl, Sabine
    Fendler, Wolfgang Peter
    Ilhan, Harun
    Rominger, Axel
    Haug, Alexander Robert
    Bartenstein, Peter
    Lehner, Sebastian
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2017, 56 (06): : 211 - 218
  • [28] Could short thyroid hormone withdrawal be an effective strategy for radioiodine remnant ablation in differentiated thyroid cancer patients?
    Piccardo, Arnoldo
    Puntoni, Matteo
    Ferrarazzo, Giulia
    Foppiani, Luca
    Bottoni, Gianluca
    Altrinetti, Vania
    Treglia, Giorgio
    Naseri, Mehrdad
    Dib, Bassam
    Cabria, Manlio
    Trimboli, Pierpaolo
    Massollo, Michela
    Giovanella, Luca
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (07) : 1218 - 1223
  • [29] Higher preablative serum thyroid-stimulating hormone level predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma
    Lawal, Ismaheel O.
    Nyakale, Nozipho E.
    Harry, Lerwine M.
    Lengana, Thabo
    Mokgoro, Neo P.
    Vorster, Mariza
    Sathekge, Mike M.
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (03) : 222 - 227
  • [30] The role of postoperative Tc-99m pertechnetate scintigraphy in estimation of remnant mass and prediction of successful ablation in patients with differentiated thyroid cancer
    Ozdemir, Didem
    Cuhaci, Fatma N.
    Ozdemir, Elif
    Aydin, Cevdet
    Ersoy, Reyhan
    Turkolmez, Seyda
    Cakir, Bekir
    NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (06) : 640 - 645
12345